After Hours
There is a slight risk associated with trading before and after the market open. Due to lower liquidity and higher volatility, extended-hours trading may result in wider spreads on particular security due to the release of critical financial information after regular trading hours.
Stocks Info
This NYSE-listed company operates within the Biotechnology industry segment, falling under the Healthcare sector. The current market capitalization of Nuvation Bio Inc is $562.21M. A total of 3.7 million shares were traded on the day, compared to an average of 2.62M shares.
In the most recent transaction, Hung David bought 300,000 shares of NUVB for 1.62 per share on Apr 07 ’25. After the transaction, the PRESIDENT AND CEO now owns 58,781,054 company shares. In a previous transaction on Apr 04 ’25, Hung David bought 200,000 shares at 1.66 per share. NUVB shares that PRESIDENT AND CEO owns now total 58,481,054.
Among the insiders who bought shares, Mashal Robert acquired of 100,000 shares on Apr 01 ’25 at a per-share price of $1.67. This resulted in the Director holding 200,000 shares of NUVB after the transaction. In another insider transaction, Wang Junyuan Jerry sold 56,361 shares at $2.89 per share on Nov 11 ’24. Company shares held by the CEO, ANHEART THERAPEUTICS LTD. now total 3,866,228.
Even though price targets are rarely accurate, they do tend to exert some kind of influence from time to time and are often considered important by markets. In terms of 52-week highs and lows, NUVB has a high of $3.97 and a low of $1.54.
As of this writing, NUVB has an earnings estimate of -$0.12 per share for the current quarter. EPS was calculated based on a consensus of 2.0 estimates, with a high estimate of -$0.11 per share and a lower estimate of -$0.13.
Balance Sheet Annually/Quarterly
In a balance sheet, you can see what assets and liabilities the company has, as well as how much equity investors have invested. These figures can be used to calculate a company’s financial ratios to give investors a better idea of its prospects. NUVB’s latest balance sheet shows that the firm has $765.39M in Cash & Short Term Investments as of fiscal 2021. There were $3.06M in debt and $16.93M in liabilities at the time. Its Book Value Per Share was $1.37, while its Total Shareholder’s Equity was $746.00M.
Analysts Opinion
The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for NUVB is Buy with a score of 4.83.
